Literature DB >> 19781963

Identification of early interstitial lung disease in smokers from the COPDGene Study.

George R Washko1, David A Lynch, Shin Matsuoka, James C Ross, Shigeaki Umeoka, Alejandro Diaz, Frank C Sciurba, Gary M Hunninghake, Raúl San José Estépar, Edwin K Silverman, Ivan O Rosas, Hiroto Hatabu.   

Abstract

RATIONALE AND
OBJECTIVES: The aim of this study is to compare two subjective methods for the identification of changes suggestive of early interstitial lung disease (ILD) on chest computed tomographic (CT) scans.
MATERIALS AND METHODS: The CT scans of the first 100 subjects enrolled in the COPDGene Study from a single institution were examined using a sequential reader and a group consensus interpretation scheme. CT scans were evaluated for the presence of parenchymal changes consistent with ILD using the following scoring system: 0 = normal, 1 = equivocal for the presence of ILD, 2 = highly suspicious for ILD, and 3 = classic ILD changes. A statistical comparison of patients with early ILD to normal subjects was performed.
RESULTS: There was a high degree of agreement between methods (kappa = 0.84; 95% confidence interval, 0.73-0.94; P < .0001 for the sequential and consensus methods). The sequential reading method had both high positive (1.0) and negative (0.97) predictive values for a consensus read despite a 58% reduction in the number of chest CT evaluations. Regardless of interpretation method, the prevalence of chest CT changes consistent with early ILD in this subset of smokers from COPDGene varied between 5% and 10%. Subjects with early ILD tended to have greater tobacco smoke exposure than subjects without early ILD (P = .053).
CONCLUSIONS: A sequential CT interpretation scheme is an efficient method for the visual interpretation of CT data. Further investigation is required to independently confirm our findings and further characterize early ILD in smokers.

Entities:  

Mesh:

Year:  2009        PMID: 19781963      PMCID: PMC2790552          DOI: 10.1016/j.acra.2009.07.016

Source DB:  PubMed          Journal:  Acad Radiol        ISSN: 1076-6332            Impact factor:   3.173


  22 in total

1.  A mutation in the surfactant protein C gene associated with familial interstitial lung disease.

Authors:  L M Nogee; A E Dunbar; S E Wert; F Askin; A Hamvas; J A Whitsett
Journal:  N Engl J Med       Date:  2001-02-22       Impact factor: 91.245

2.  Adult familial cryptogenic fibrosing alveolitis in the United Kingdom.

Authors:  R P Marshall; A Puddicombe; W O Cookson; G J Laurent
Journal:  Thorax       Date:  2000-02       Impact factor: 9.139

3.  Clinical and pathologic features of familial interstitial pneumonia.

Authors:  Mark P Steele; Marcy C Speer; James E Loyd; Kevin K Brown; Aretha Herron; Susan H Slifer; Lauranell H Burch; Momen M Wahidi; John A Phillips; Thomas A Sporn; H Page McAdams; Marvin I Schwarz; David A Schwartz
Journal:  Am J Respir Crit Care Med       Date:  2005-08-18       Impact factor: 21.405

4.  Spirometric reference values from a sample of the general U.S. population.

Authors:  J L Hankinson; J R Odencrantz; K B Fedan
Journal:  Am J Respir Crit Care Med       Date:  1999-01       Impact factor: 21.405

Review 5.  Idiopathic pulmonary fibrosis.

Authors:  T J Gross; G W Hunninghake
Journal:  N Engl J Med       Date:  2001-08-16       Impact factor: 91.245

6.  Nationwide prevalence of sporadic and familial idiopathic pulmonary fibrosis: evidence of founder effect among multiplex families in Finland.

Authors:  U Hodgson; T Laitinen; P Tukiainen
Journal:  Thorax       Date:  2002-04       Impact factor: 9.139

7.  Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model.

Authors:  T E King; J A Tooze; M I Schwarz; K R Brown; R M Cherniack
Journal:  Am J Respir Crit Care Med       Date:  2001-10-01       Impact factor: 21.405

Review 8.  Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy.

Authors:  M Selman; T E King; A Pardo
Journal:  Ann Intern Med       Date:  2001-01-16       Impact factor: 25.391

Review 9.  Smoking-related interstitial lung disease: radiologic-clinical-pathologic correlation.

Authors:  Anil K Attili; Ella A Kazerooni; Barry H Gross; Kevin R Flaherty; Jeffrey L Myers; Fernando J Martinez
Journal:  Radiographics       Date:  2008 Sep-Oct       Impact factor: 5.333

10.  Familial idiopathic pulmonary fibrosis. Evidence of lung inflammation in unaffected family members.

Authors:  P B Bitterman; S I Rennard; B A Keogh; M D Wewers; S Adelberg; R G Crystal
Journal:  N Engl J Med       Date:  1986-05-22       Impact factor: 91.245

View more
  98 in total

1.  Vertical gradients in regional alveolar oxygen tension in supine human lung imaged by hyperpolarized 3He MRI.

Authors:  Hooman Hamedani; Hoora Shaghaghi; Stephen J Kadlecek; Yi Xin; Biao Han; Sarmad Siddiqui; Jennia Rajaei; Masaru Ishii; Milton Rossman; Rahim R Rizi
Journal:  NMR Biomed       Date:  2014-12       Impact factor: 4.044

2.  Visually stratified CT honeycombing as a survival predictor in combined pulmonary fibrosis and emphysema.

Authors:  Yong Seek Kim; Gong Yong Jin; Kum Ju Chae; Young Min Han; Su Bin Chon; Young Sun Lee; Keun Sang Kwon; Hye Mi Choi
Journal:  Br J Radiol       Date:  2015-09-21       Impact factor: 3.039

3.  Interstitial lung abnormalities in treatment-naïve advanced non-small-cell lung cancer patients are associated with shorter survival.

Authors:  Mizuki Nishino; Stephanie Cardarella; Suzanne E Dahlberg; Tetsuro Araki; Christine Lydon; David M Jackman; Michael S Rabin; Hiroto Hatabu; Bruce E Johnson
Journal:  Eur J Radiol       Date:  2015-02-07       Impact factor: 3.528

Review 4.  Interstitial lung abnormalities: risk and opportunity.

Authors:  Samuel Y Ash; George R Washko
Journal:  Lancet Respir Med       Date:  2017-02       Impact factor: 30.700

5.  High-Attenuation Areas on Chest Computed Tomography and Clinical Respiratory Outcomes in Community-Dwelling Adults.

Authors:  Anna J Podolanczuk; Elizabeth C Oelsner; R Graham Barr; Elana J Bernstein; Eric A Hoffman; Imaani J Easthausen; Karen Hinckley Stukovsky; Arindam RoyChoudhury; Erin D Michos; Ganesh Raghu; Steven M Kawut; David J Lederer
Journal:  Am J Respir Crit Care Med       Date:  2017-12-01       Impact factor: 21.405

6.  Collagen biomarkers and subclinical interstitial lung disease: The Multi-Ethnic Study of Atherosclerosis.

Authors:  Purnema Madahar; Daniel A Duprez; Anna J Podolanczuk; Elana J Bernstein; Steven M Kawut; Ganesh Raghu; R Graham Barr; Myron D Gross; David R Jacobs; David J Lederer
Journal:  Respir Med       Date:  2018-06-06       Impact factor: 3.415

Review 7.  The expanding role of biomarkers in the assessment of smoking-related parenchymal lung diseases.

Authors:  Tracy J Doyle; Victor Pinto-Plata; Danielle Morse; Bartolome R Celli; Ivan O Rosas
Journal:  Chest       Date:  2012-10       Impact factor: 9.410

8.  Reference values for high attenuation areas on chest CT in a healthy, never-smoker, multi-ethnic sample: The MESA study.

Authors:  Imaani Easthausen; Anna Podolanczuk; Eric Hoffman; Steven Kawut; Elizabeth Oelsner; John S Kim; Ganesh Raghu; Karen Hinckley Stukovsky; Susan Redline; Robyn L McClelland; R Graham Barr; David J Lederer
Journal:  Respirology       Date:  2020-02-17       Impact factor: 6.424

9.  Circulating adhesion molecules and subclinical interstitial lung disease: the Multi-Ethnic Study of Atherosclerosis.

Authors:  Claire F McGroder; Carrie P Aaron; Suzette J Bielinski; Steven M Kawut; Russell P Tracy; Ganesh Raghu; R Graham Barr; David J Lederer; Anna J Podolanczuk
Journal:  Eur Respir J       Date:  2019-09-30       Impact factor: 16.671

10.  A SR-NET 3D-TO-2D ARCHITECTURE FOR PARASEPTAL EMPHYSEMA SEGMENTATION.

Authors:  D Bermejo-Peláez; Y Okajima; G R Washko; M J Ledesma-Carbayo; R San José Estépar
Journal:  Proc IEEE Int Symp Biomed Imaging       Date:  2019-07-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.